Cargando…

Prediction of outcome after diagnosis of metachronous contralateral breast cancer

BACKGROUND: Although 2-20% of breast cancer patients develop a contralateral breast cancer (CBC), prognosis after CBC is still debated. Using a unique patient cohort, we have investigated whether time interval to second breast cancer (BC2) and mode of detection are associated to prognosis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkner, Sara, Bendahl, Pär-Ola, Fernö, Mårten, Manjer, Jonas, Rydén, Lisa
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080341/ https://www.ncbi.nlm.nih.gov/pubmed/21450091 http://dx.doi.org/10.1186/1471-2407-11-114

Ejemplares similares

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
por: Alkner, Sara, et al.
Publicado: (2016)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
por: Tutzauer, Julia, et al.
Publicado: (2020)

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
por: Falck, Anna-Karin, et al.
Publicado: (2013)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor
por: Narbe, Ulrik, et al.
Publicado: (2014)

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
por: Forsare, Carina, et al.
Publicado: (2018)

Co-localization of CD169(+) macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
por: Björk Gunnarsdottir, Frida, et al.
Publicado: (2020)

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
por: Jansson, Sara, et al.
Publicado: (2014)

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
por: Lundgren, Christine, et al.
Publicado: (2020)

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing
por: Alkner, Sara, et al.
Publicado: (2015)

Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
por: Lundgren, Christine, et al.
Publicado: (2023)

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2020)

A novel model for Ki67 assessment in breast cancer
por: Romero, Quinci, et al.
Publicado: (2014)

The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance
por: Narbe, Ulrik, et al.
Publicado: (2020)

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
por: Alkner, S., et al.
Publicado: (2017)

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
por: Lundgren, Christine, et al.
Publicado: (2022)

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
por: Falck, Anna-Karin, et al.
Publicado: (2012)

Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status
por: Lidfeldt, Jon, et al.
Publicado: (2015)

Artificial neural network models to predict nodal status in clinically node-negative breast cancer
por: Dihge, Looket, et al.
Publicado: (2019)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Inasu, Maria, et al.
Publicado: (2021)

Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial
por: Alkner, Sara, et al.
Publicado: (2023)

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
por: Jansson, Sara, et al.
Publicado: (2016)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer
por: Majid, S, et al.
Publicado: (2021)

The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology
por: Dihge, Looket, et al.
Publicado: (2016)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
por: Dihge, Looket, et al.
Publicado: (2023)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients
por: Majid, Shabaz, et al.
Publicado: (2018)

Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study
por: Mohlin, Åsa, et al.
Publicado: (2021)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Traumatic Metachronous Penile Fracture to the Contralateral Corpora
por: Papaioannou, Christos, et al.
Publicado: (2022)

Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development
por: Hjärtström, Malin, et al.
Publicado: (2023)

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
por: Aaltonen, Kristina E., et al.
Publicado: (2017)

The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
por: Skarping, Ida, et al.
Publicado: (2022)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
por: Jumppanen, Mervi, et al.
Publicado: (2007)

The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
por: Skarping, Ida, et al.
Publicado: (2022)

The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer
por: Strand, Carina, et al.
Publicado: (2013)

Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
por: Jögi, Annika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_smjdm9r8jsel6anml2gbb9s1ae